UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment

Breast cancer research and treatment, 2021-02, Vol.186 (1), p.219-227

2021

Volltextzugriff (PDF)

Fungal burden, dimorphic transition and candidalysin: Role in Candida albicans-induced vaginal cell damage and mitochondrial activation in vitro

PloS one, 2024-05, Vol.19 (5), p.e0303449-e0303449

2024

Volltextzugriff (PDF)

Lactobacillus acidophilus, L. plantarum, L. rhamnosus, and L. reuteri Cell-Free Supernatants Inhibit Candida parapsilosis Pathogenic Potential upon Infection of Vaginal Epithelial Cells Monolayer and in a Transwell Coculture System In Vitro

Microbiology spectrum, 2022-06, Vol.10 (3), p.e0269621-e0269621

2022

Volltextzugriff (PDF)

A New Phenotype in Candida -Epithelial Cell Interaction Distinguishes Colonization- versus Vulvovaginal Candidiasis-Associated Strains

mBio, 2023-04, Vol.14 (2), p.e0010723-e0010723

2023

Volltextzugriff (PDF)

A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification products

PloS one, 2018-03, Vol.13 (3), p.e0193689-e0193689

2018

Volltextzugriff (PDF)

Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance

Molecular cancer, 2014-06, Vol.13 (1), p.143-143, Article 143

2014

Volltextzugriff (PDF)

Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines

Molecular cancer, 2012-12, Vol.11 (1), p.91-91, Article 91

2012

Volltextzugriff (PDF)

Molecular Mechanisms Underlying the Antitumor Activity of 3-Aminopropanamide Irreversible Inhibitors of the Epidermal Growth Factor Receptor in Non–Small Cell Lung Cancer

Neoplasia (New York, N.Y.), 2013, Vol.15 (1), p.61-IN18

2013

Volltextzugriff (PDF)

Elective palliative resection of incurable stage IV colorectal cancer: Who really benefits from it?

Surgery today (Tokyo, Japan), 2011-02, Vol.41 (2), p.222-229

2011

Volltextzugriff (PDF)

Predictors of survival to immunotherapy and chemoimmunotherapy in non-small cell lung cancer: A meta-analysis

JNCI : Journal of the National Cancer Institute, 2023-01, Vol.115 (1), p.29-42

2023

Volltextzugriff (PDF)

Skin Toxicities with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Signals from Disproportionality Analysis of the FDA Adverse Event Reporting System

American journal of clinical dermatology, 2022-03, Vol.23 (2), p.247-255

2022

Volltextzugriff (PDF)

Impact of Clinicopathological Features on Survival in Patients Treated with First-line Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma: A Meta-analysis of Randomized Clinical Trials

European urology focus, 2022-03, Vol.8 (2), p.514-521

2022

Volltextzugriff (PDF)

Effective retreatment with osimertinib in CNS-relapsed epidermal growth factor receptor-mutant non-small cell lung cancer patient following resection and adjuvant osimertinib

Anti-cancer drugs, 2024-01, Vol.35 (1), p.86

2024

Volltextzugriff (PDF)

Fading With Time of PD-L1 Immunoreactivity in Non-Small Cells Lung Cancer Tissues: A Methodological Study

Applied immunohistochemistry & molecular morphology, 2018-08, Vol.26 (7), p.489-494

2018

Volltextzugriff (PDF)

Patterns of renal toxicity from the combination of pemetrexed and pembrolizumab for advanced nonsquamous non-small-cell lung cancer (NSCLC): A single-center experience

Lung cancer (Amsterdam, Netherlands), 2022-12, Vol.174, p.91-96

2022

Volltextzugriff (PDF)

The pathogenic and colonization potential of Candida africana

Microbes and infection, 2024-01, Vol.26 (1-2), p.105230, Article 105230

2024

Volltextzugriff (PDF)

Cabozantinib‐related cardiotoxicity: a prospective analysis in a real‐world cohort of metastatic renal cell carcinoma patients

British journal of clinical pharmacology, 2019-06, Vol.85 (6), p.1283-1289

2019

Volltextzugriff (PDF)

First-Line Chemotherapy Treatment of Advanced Non–Small-Cell Lung Cancer: Does Cisplatin versus Carboplatin Make a Difference?

Journal of thoracic oncology, 2014-11, Vol.9 (11), p.e82-e82

2014

Volltextzugriff (PDF)

Second-line Treatment of Small Cell Lung Cancer: Is Platinum Sensitivity a Relevant Prognostic Factor?

Journal of thoracic oncology, 2015-05, Vol.10 (5), p.e35-e36

2015

Volltextzugriff (PDF)

Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME)

Cancer treatment reviews, 2018-12, Vol.71, p.76-87

2018

Volltextzugriff (PDF)

Colony-stimulating factors for febrile neutropenia

The New England journal of medicine, 2013-07, Vol.369 (3), p.285

2013

Volltextzugriff (PDF)

Activity and safety of dose‐adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor‐prognostic untreated diffuse large B‐cell non‐Hodgkin lymphoma

Cancer, 2011-03, Vol.117 (5), p.964-973

2011

Volltextzugriff (PDF)

BOLERO-3 results: pharmacological activity or pharmacokinetic effect?

The lancet oncology, 2014-07, Vol.15 (8), p.e304-e304

2014

Volltextzugriff (PDF)

Overcoming Primary Resistance to PD-1 Inhibitor With Anti–PD-L1 Agent in Squamous-Cell NSCLC: Case Report

Clinical lung cancer, 2020-03, Vol.21 (2), p.e45-e48

2020

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(35)

Sprache

Englisch
(35)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment

Fungal burden, dimorphic transition and candidalysin: Role in Candida albicans-induced vaginal cell damage and mitochondrial activation in vitro

Lactobacillus acidophilus, L. plantarum, L. rhamnosus, and L. reuteri Cell-Free Supernatants Inhibit Candida parapsilosis Pathogenic Potential upon Infection of Vaginal Epithelial Cells Monolayer and in a Transwell Coculture System In Vitro

A New Phenotype in Candida -Epithelial Cell Interaction Distinguishes Colonization- versus Vulvovaginal Candidiasis-Associated Strains

A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification products

Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance

Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines

Molecular Mechanisms Underlying the Antitumor Activity of 3-Aminopropanamide Irreversible Inhibitors of the Epidermal Growth Factor Receptor in Non–Small Cell Lung Cancer

Elective palliative resection of incurable stage IV colorectal cancer: Who really benefits from it?

Predictors of survival to immunotherapy and chemoimmunotherapy in non-small cell lung cancer: A meta-analysis

Skin Toxicities with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Signals from Disproportionality Analysis of the FDA Adverse Event Reporting System

Impact of Clinicopathological Features on Survival in Patients Treated with First-line Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma: A Meta-analysis of Randomized Clinical Trials

Effective retreatment with osimertinib in CNS-relapsed epidermal growth factor receptor-mutant non-small cell lung cancer patient following resection and adjuvant osimertinib

Fading With Time of PD-L1 Immunoreactivity in Non-Small Cells Lung Cancer Tissues: A Methodological Study

Patterns of renal toxicity from the combination of pemetrexed and pembrolizumab for advanced nonsquamous non-small-cell lung cancer (NSCLC): A single-center experience

The pathogenic and colonization potential of Candida africana

Cabozantinib‐related cardiotoxicity: a prospective analysis in a real‐world cohort of metastatic renal cell carcinoma patients

First-Line Chemotherapy Treatment of Advanced Non–Small-Cell Lung Cancer: Does Cisplatin versus Carboplatin Make a Difference?

Second-line Treatment of Small Cell Lung Cancer: Is Platinum Sensitivity a Relevant Prognostic Factor?

Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME)

Colony-stimulating factors for febrile neutropenia

Activity and safety of dose‐adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor‐prognostic untreated diffuse large B‐cell non‐Hodgkin lymphoma

BOLERO-3 results: pharmacological activity or pharmacokinetic effect?

Overcoming Primary Resistance to PD-1 Inhibitor With Anti–PD-L1 Agent in Squamous-Cell NSCLC: Case Report

Aktive Filter

Suchergebnisse filtern